- Home
- HTGC vs ZLAB Comparison
HTGC vs ZLAB Comparison
Compare HTGC & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTGC
- ZLAB
- Stock Information
- Founded
- HTGC 2003
- ZLAB 2013
- Country
- HTGC United States
- ZLAB China
- Employees
- HTGC N/A
- ZLAB N/A
- Industry
- HTGC Investment Managers
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- HTGC Finance
- ZLAB Health Care
- Exchange
- HTGC Nasdaq
- ZLAB Nasdaq
- Market Cap
- HTGC 3.2B
- ZLAB 3.6B
- IPO Year
- HTGC 2005
- ZLAB 2017
- Fundamental
- Price
- HTGC $17.57
- ZLAB $31.19
- Analyst Decision
- HTGC Buy
- ZLAB Buy
- Analyst Count
- HTGC 8
- ZLAB 4
- Target Price
- HTGC $20.81
- ZLAB $47.37
- AVG Volume (30 Days)
- HTGC 1.5M
- ZLAB 937.3K
- Earning Date
- HTGC 05-01-2025
- ZLAB 05-08-2025
- Dividend Yield
- HTGC 10.70%
- ZLAB N/A
- EPS Growth
- HTGC N/A
- ZLAB N/A
- EPS
- HTGC 1.33
- ZLAB N/A
- Revenue
- HTGC $491,549,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- HTGC $7.53
- ZLAB $44.07
- Revenue Next Year
- HTGC $9.61
- ZLAB $49.13
- P/E Ratio
- HTGC $13.20
- ZLAB N/A
- Revenue Growth
- HTGC 3.02
- ZLAB 43.72
- 52 Week Low
- HTGC $15.65
- ZLAB $16.01
- 52 Week High
- HTGC $22.04
- ZLAB $39.77
- Technical
- Relative Strength Index (RSI)
- HTGC 47.85
- ZLAB 50.80
- Support Level
- HTGC $17.35
- ZLAB $30.11
- Resistance Level
- HTGC $17.74
- ZLAB $31.34
- Average True Range (ATR)
- HTGC 0.28
- ZLAB 1.14
- MACD
- HTGC 0.02
- ZLAB 0.07
- Stochastic Oscillator
- HTGC 54.76
- ZLAB 62.48
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.